Independent research tool — not a government agency. Official notices govern.Refreshed
GrantsJunctionAmerican funding, sourcedMethodology
ClosedDeadline extended (was May 2, 2021)Opportunity CDC-RFA-GH21-2157

Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR

Centers for Disease Control - CGH · Department of Health and Human Services

At a glance

Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR is a closed federal cooperative agreement opportunity from the Centers for Disease Control - CGH (Department of Health and Human Services). The application deadline was May 14, 2021. Applicant types listed as eligible include others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.067 (Global AIDS).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Mar 3, 2021Posted
  2. May 14, 2021Application deadline
Posted
Mar 3, 2021
Close date
May 14, 2021
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
Not specified
Original deadline (extended)
May 2, 2021
Expected awards
1
Cost sharing
Not required
Funding instrument
Cooperative Agreement
Opportunity category
Discretionary

Typical awards for this program (SAM.gov listing for ALN 93.067, not this notice): Range: $1,600,000,000 to $1,700,000,000. Average $1,655,000,000

Who can apply

  • Others (see notice)

Additional information on eligibility (from the notice)

Eligible applicants that can apply for this NOFO are: Namibia Institute of Pathology (NIP)

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,500,000 for Year 1, subject to the availability of funds.
Over the next five years, diagnostic network optimization (DNO) within the laboratory system will be the primary overarching activity since it pinpoints deficiencies and strengthens the identified gaps remaining to reach sustained epidemic control of HIV and TB in Namibia, as well as responds to outbreak needs as they occur. Broadly, the activities under this NOFO will include: 1) the establishment of a national transport system using the Namibia Institute of Pathology (NIP) system as a base, 2) workflow analyses to assess testing needs based on number of patients on antiretroviral therapy (ART), 3) assessment of instrument utilization, and 4) establishment of a national unique patient identifier. These activities will enable the country to better track patients from one viral load (VL) test to the next to ensure suppression rates are accurate for all patients on ART, enhance and expand infant diagnosis to greater than the current 80% coverage, and ensure that all HIV patients that are dually infected with TB are diagnosed and treated. 

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

Assistance Listing

What is an ALN?

Reported obligations under ALN 93.067

Historical data · not a prediction
FY24$1.66B
FY25$887M
FY26$502M est.
Source: SAM.gov Assistance Listing 93.067. Program-wide totals, not awards from this specific opportunity.

Who was funded under ALN 93.067

Historical data · not a prediction

Since October 1, 2023, 108 grant awards had funding actions under Global AIDS, with 51 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.

  1. THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK$221M
  2. ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION$111M
  3. MANAGEMENT AND DEVELOPMENT FOR HEALTH$84.8M
  4. CENTER FOR INTERNATIONAL HEALTH, EDUCATION AND BIOSECURITY - KENYA$70.7M
  5. WITS HEALTH CONSORTIUM (PTY) LTD$69M
Recipients, states, recent awards and sub-awards →Source: USAspending.gov.

Agency contact (as published)

Centers for Disease Control - CGH
dln6@cdc.gov
770-488-2756

Quick answers

Who is eligible to apply for this opportunity?

The official notice names these applicant types as eligible: Others (see notice). Additional restrictions may apply; review the full notice.

How do I apply for this opportunity?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity CDC-RFA-GH21-2157), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedALN 93.088

Pregnancy and Postpartum Hypertension Control Initiative

Office of the Assistant Secretary for Health
Award range
$300K – $550K
Est. close
Jul 16, 2025 (est.)
Who can apply
State governments, County governments, City or township governments and 11 more
Source: Grants.govVerified yesterday